The Inflation Reduction Act Expands Prescription Drug Affordability Decades in the Making

被引:1
|
作者
Zheng, Jimmy [1 ,4 ]
Sandhu, Alexander T. [2 ,3 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA USA
[3] Palo Alto Vet Affairs Hosp, Dept Med, Palo Alto, CA USA
[4] Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA
关键词
cost-sharing; health expenditures; health policy; Medicare; prescription drugs;
D O I
10.1016/j.jacc.2023.03.415
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2112 / 2114
页数:3
相关论文
共 50 条
  • [41] A summit on amplifying voices of patients, caregivers, and people with disabilities in Inflation Reduction Act drug price negotiations
    Miller, Maxine
    van Geertruyden, Sara
    Saxton, M. Claire
    Savage, Courtney Yohe
    Weir, Debbie
    Werner, Sally
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (03): : 247 - 251
  • [42] The Medicare Prescription Drug Improvement and Modernization Act: Prescription drugs and academic medicine
    Frencher, Stanley K., Jr.
    Glied, Sherry
    [J]. ACADEMIC MEDICINE, 2006, 81 (09) : 812 - 816
  • [43] The Medicare Prescription Drug, Improvement, and Modernization Act of 2003
    Emmer, S
    Allendorf, L
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (06) : 1013 - 1015
  • [44] Anticipating Reforms to the Prescription Drug User Fees Act
    Ballreich, Jeromie
    Socal, Mariana
    Anderson, Gerard F.
    [J]. JAMA NETWORK OPEN, 2022, 5 (11) : e2239341
  • [45] The prescription drug marketing act: A solution in search of a problem?
    Angarola, RT
    Beach, JE
    [J]. FOOD AND DRUG LAW JOURNAL, 1996, 51 (01): : 21 - 55
  • [46] The Prescription Drug User Fee Act: Cause for Concern?
    Gabay, Michael
    [J]. HOSPITAL PHARMACY, 2018, 53 (02) : 88 - 89
  • [47] A Prescription for Improving Drug Formulary Decision Making
    Schiff, Gordon D.
    Galanter, William L.
    Duhig, Jay
    Koronkowski, Michael J.
    Lodolce, Amy E.
    Pontikes, Pam
    Busker, John
    Touchette, Daniel
    Walton, Surrey
    Lambert, Bruce L.
    [J]. PLOS MEDICINE, 2012, 9 (05)
  • [48] INFLATION REDUCTION ACT: ASSESSING THE IMPACT FOR NEW DRUG DEVELOPMENT, LAUNCH, LIFE CYCLE MANAGEMENT AND LOSS OF EXCLUSIVITY
    Briggs, S.
    Francois, C.
    Auger, E.
    Busch, A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S228 - S228
  • [49] Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act
    Narasimmaraj, Prihatha R.
    Oseran, Andrew
    Tale, Archana
    Xu, Jiaman
    Essien, Utibe R.
    Kazi, Dhruv S.
    Yeh, Robert W.
    Wadhera, Rishi K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (15) : 1491 - 1501
  • [50] Impact of the Inflation Reduction Act for Patients With Advanced Prostate Cancer
    Pockros, Benjamin
    Stensland, Kristian
    Shahinian, Vahakn
    [J]. UROLOGY PRACTICE, 2023, 10 (06) : 537 - 539